טוען...
The Efficacy of Continuous Versus Intermittent Celecoxib Treatment in Osteoarthritis Patients with Body Mass Index ≥30 and <30 kg/m(2)
OBJECTIVE: Characterize the effect of body mass index (BMI) on the efficacy of continuous daily celecoxib treatment compared with intermittent celecoxib treatment. METHODS: Prespecified exploratory analysis of a 24-week, double-blind, parallel-group, randomized, multicenter international study. 858...
שמור ב:
Main Authors: | , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Bentham Open
2013
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3731795/ https://ncbi.nlm.nih.gov/pubmed/23919092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312901307010032 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|